|
|
SPOT ON
|
|
Transparency good bye - u-turn of EMA concerning drug trial data
|
|
|
NEW ON THE MARKET
|
|
Insulin degludec (TRESIBA) for diabetes mellitus
|
|
|
REVIEW
|
|
Tick-borne encephalitis (II)
|
|
|
IN BRIEF
|
|
Ivabradine (PROCOROLAN) - increase of cardiovascular complications in patients with angina pectoris
Risk-benefit assessment of ambroxol (MUCOSOLVAN, generics) and bromhexin (BISOLVON, generics)
US poison centers - red flag about electronic cigarettes
Now after all: early benefit assessment of dimethyl fumarate
|
|
Warning about Miracle Mineral Supplement (MMS) miracle cure
|
|
|
CURRENT ADR NETWORK REPORT
|
|
ROLENIUM ELPENHALER (fluticasone propionate + salmeterol): use prone to errors
|
|
|
SIDE EFFECTS
|
|
Quetiapin (SEROQUEL, generics) - acute liver failure and ischemic colitis
|
|
|
e a-t IN INTERNET
|
|
Aspirin without benefit for primary prevention of heart attack and stroke
|
|